Optimize your Field Medical Team for the OmniChannel World
This white paper by the MAPS Field Medical FAWG details strategies for optimizing your Field Medical team for the OmniChannel World
This white paper by the MAPS Field Medical FAWG details strategies for optimizing your Field Medical team for the OmniChannel World
In the second podcast of this two-part series, we will discuss communicating the value of Field Medical to external stakeholders.
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
In today’s episode, our Field Medical experts will discuss tips to understand how you can lead through change.
In today’s episode, our Field Medical experts will discuss tips to understand how you can lead through change.
This webinar will be covering:
1.   Looking into the future of MA in Japan
a.   How to engage more with Patients/Patient Advocacy groups
b.   How to bring more value to customers, scientific leaders and health systems
c.    How to better engage academia and health authority group through scientific exchange
2.   Opportunities for improving effectiveness
a.   Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?
During this webinar, experts will:
Medical Affairs is a function within the biopharmaceutical, consumer healthcare, and MedTech industries that sits alongside other functions including Research & Development (R&D) and Commercial as one of the strategic pillars of the industry. R&D develops new drugs, devices and diagnostics; Commercial markets and sells these products; and Medical Affairs generates and communicates data that help healthcare professionals (HCPs), payors, policy makers and others make informed decisions that ensure the best use of treatments to benefit patients. In this way, Medical Affairs plays a vital role in providing scientific evidence and understanding to appropriately change clinical practice.
Just as there are many roles within R&D and Commercial, individuals working within Medical Affairs are responsible for many activities, especially including the following:
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.